2023 Insights event brings pharma and Prime/MRx leaders together

More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer

November 2, 2023

The Insights event took place in Orange County, CA where Prime/MRx trade team members and executives shared company updates and networked with key industry representatives and pharmaceutical manufacturers.

On the agenda

Topic-focused presentations:

  • A government affairs update
  • The latest information on oncology programs, including IntegratedRx®
  • Health outcomes case studies on value-based contracting, GLP-1 and HighTouchRx®
  • A specialty drug management session

Informative panels: Two panels gave the pharma audience a chance to ask the Prime/MRx team questions on their minds.

  • The first as a fireside chat featuring pharmacy benefit management leadership addressing topics including the Prime/MRx integration, corporate strategy and future vision.
  • The second panel included a rotating cast of trade team members representing all lines of business addressing how Prime/MRx and pharma can best work together to maximize patient outcomes.

Networking: The event opened with an evening reception before the formal program began. The reception included a “speed networking” session to close out Day 1 aimed at mixing up attendees and staff in a casual, get-to-know-you format.

“I have received incredible feedback from our attendees on the success of this year’s Insights event. Everyone enjoyed the location, the content and the networking. We look forward to continuing to advance our relationship with pharma through this event and other connections throughout the year,” said Emily Colaizy, assistant vice president, pharmaceutical trade relations.

Related news

Stories

July 22, 2024

Introducing the latest issue of our medical and pharmacy benefit management report

The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care

Stories

July 18, 2024

Specialty drug trend forecasted to drop for employer groups, clinical experts say

Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend

Stories

July 16, 2024

Prime/Magellan Rx earns top score on the Disability Equality Index

For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion